Loading market dashboard

Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
Pelthos Therapeutics Inc. · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Dec 2030 | $244.79M | $218.23M - $306.42M | $146.87M | $7.312 | 2 |
| Dec 2029 | $206.60M | $184.18M - $258.61M | $123.96M | $4.996 | 2 |
| Dec 2028 | $170.26M | $167.21M - $173.31M | $102.16M | $3.443 | 5 |
| Dec 2027 | $117.55M | $105.70M - $147.32M | $70.53M | -$1.667 | 5 |
| Dec 2026 | $63.68M | $57.68M - $75.07M | $38.21M | -$10.351 | 6 |
| Dec 2025 | $16.59M | $16.28M - $16.86M | $9.96M | -$15.98 | 5 |